Our previous studies have indicated lower serum levels of CTRP13 in other metabolic disorders including fatty liver, diabetes and coronary artery disease [26–28].In humans, CTRP13 is expressed predominantly by adipose tissue [22]. This evidence concerns the gene C1QL3 and metabolic disease.